Unicycive Therapeutics (UNCY) Prepaid Assets (2020 - 2026)
Unicycive Therapeutics' (UNCY) quarterly Prepaid Assets came in at $181000.0 in Q1 2026, down 86.77% YoY from $1.4 million in Q1 2025, and down 84.54% on a QoQ basis from $1.2 million in Q4 2025.
Unicycive Therapeutics (UNCY) Prepaid Assets (2020 - 2026) Analysis & Trends
Unicycive Therapeutics (UNCY) has 7 years of Prepaid Assets data on file, last reported at $181000.0 in Q1 2026.
- Quarterly Prepaid Assets fell 86.77% year-over-year to $181000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $181000.0 (down 86.77% YoY) and the FY2025 annual result came in at $1.2 million, up 24.71% from the prior year.
- Prepaid Assets eased to $181000.0 in Q1 2026, from $1.2 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $7.6 million in Q3 2025 to a low of $15000.0 in Q2 2025.
- A 5-year average of $2.0 million and a median of $1.8 million in 2022 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2022 — Prepaid Assets jumped 19770.0% — and 2025, when it plunged 99.34%.
- Tracing UNCY's Prepaid Assets over 5 years: stood at $159000.0 in 2022, then jumped by 2225.79% to $3.7 million in 2023, then tumbled by 74.61% to $939000.0 in 2024, then gained by 24.71% to $1.2 million in 2025, then tumbled by 84.54% to $181000.0 in 2026.
- The last three Prepaid Assets figures came in at $181000.0 (Q1 2026), $1.2 million (Q4 2025), and $7.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Unicycive Therapeutics | 151.01 Mn | 151.01 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.90 Mn |
| Mar 31, 2026 | 181,000.00 |
| Dec 31, 2025 | 1.17 Mn |
| Sep 30, 2025 | 7.59 Mn |
| Jun 30, 2025 | 15,000.00 |
| Mar 31, 2025 | 1.37 Mn |
| Dec 31, 2024 | 939,000.00 |
| Sep 30, 2024 | 687,000.00 |
| Jun 30, 2024 | 2.27 Mn |
| Mar 31, 2024 | 2.75 Mn |
| Dec 31, 2023 | 3.70 Mn |
| Sep 30, 2023 | 682,000.00 |
| Jun 30, 2023 | 3.11 Mn |
| Mar 31, 2023 | 1.85 Mn |
| Dec 31, 2022 | 159,000.00 |
| Sep 30, 2022 | 2.95 Mn |
| Jun 30, 2022 | 1.99 Mn |
| Mar 31, 2022 | 1.84 Mn |
| Dec 31, 2021 | 1.83 Mn |
| Sep 30, 2021 | 58,000.00 |